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Patient 1. A 22-year-old diabetic male came to the Emergency Room
of the Medical College of Virginia Hospitals with an infected toe,
polyuria, weight loss, and shortness of breath for several days.
Diabetes mellitus had been diagnosed 9 years earlier. The patient had
had 3 previous episodes of diabetic ketoacidosis, the most recent 2
years previously. He had recently been managed with 32 Units of NPH
and 6 units of regular insulin in the morning, and 12 units of NPH in the
evening. Because of a "busy schedule," however, he had not taken his
evening insulin for at least 6 days. Approximately 2 weeks prior to
presentation, he had noted a blister on his right great toe after wearing
a new pair of shoes. Over the past week the toe had become redder and
warmer and had exuded a yellow discharge. Although he had monitored
his blood sugar levels in the past, he had not done so for more than one
month. Despite a good appetite, he had lost 8 pounds over the previous
2 weeks.
On physical examination, the patient was a young, thin white male
with rapid, deep respirations. His supine blood pressure was 110/70 mm
Hg, dropping to 96/60mm Hg on standing. The pulse was 116 beats/mm;
respiratory rate, 28/mm; temperature, 38°C; and weight, 65 kg. There
were several microaneurysms in the right optic fundus, the neck veins
were flat at 30°, and the lungs were clear. Cardiac examination disclosed
a grade Il/VI systolic murmur. Mild epigastric tenderness was present,
as was a swollen, warm, tender right great toe with purulent discharge.
Laboratory studies revealed: plasma sodium, 138 mEq/liter; potas-
sium, 5.4 mEq/liter; chloride, 100 mEq/liter; total carbon dioxide, 12
mM/liter; glucose, 450 mg/dl; urea nitrogen, 30 mg/dl; and serum
creatinine, 3.1 mg/dl. Serum ketones were present at 1:8 dilution. An
arterial blood gas sample disclosed: pH, 7.20; pCO2, 26 mm Hg; p02,
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112 mm Hg; and calculated bicarbonate, 9.9 mEq/liter. Urinalysis
revealed pH 5.0, no protein, > 200 mg/dl glucose, and 4+ ketones;
microscopic examination disclosed 1—2 white blood cells/high-power
field and occasional hyaline and granular casts. The hemoglobin was
13.2 gldl; hematocrit, 40.6%; and white blood cell count, 7500/mm3. A
24-hour urine collection begun 12 hours after admission contained 186
mEq ammonium.
The patient was admitted and treated with intravenous sodium
chloride, insulin, potassium, antibiotics, and local care to the toe. With
correction of the hyperglycemia, extracellular volume depletion, and
metabolic acidosis, his clinical condition improved; the ketonemia
cleared, and the infected toe gradually healed. A regimen of split-dose
NPH and regular insulin was restarted and he received additional
diabetic teaching. He was discharged with followup by the Diabetes
Clinic.
Patient 2. A 25-year-old male prison inmate was brought to the
Emergency Room of the Medical College of Virginia Hospitals because
of malaise, fatigue, and chest discomfort over several weeks. He was
sent to the hospital when laboratory studies at the prison infirmary
revealed severe anemia, hyperkalemia, acidosis, and azotemia.
He had experienced transient gross hematuria at age 12 and sickle cell
anemia was diagnosed at that time. During his childhood he had had
only rare episodes of pain, usually involving his shoulders, knees, and
abdomen, but he had not required transfusions or hospitalization. Gross
hematuria had not recurred and he had had few symptoms over the
previous 5 years, with the exception of several episodes of priapism.
Four months prior to admission, he developed lateral malleolar ulcers,
which were treated with local care and intermittent antibiotic therapy.
Following incarceration, he had a positive skin test for tuberculosis;
rifampin therapy was initiated. A urinalysis disclosed microhematuria
and pyuria, and ciprofloxacin was added to his regimen; he received
these medications up to the time of admission. He denied illicit drug
use, a history of hypertension, or urinary symptoms, with the exception
of nocturia and possible polyuria for several months.
On physical examination, the patient was an alert, young black male
in no acute distress. His supine blood pressure was 150/70 mm Hg;
pulse, 86 beats/mm, without postural change; and weight, 64 kg. The
conjunctivae were pale, the lungs were clear, a grade Ill/VI systolic
murmur and S4 gallop were present, and there was no edema. A healing
malleolar ulcer was present on the right leg.
Laboratory studies revealed: plasma sodium, 136 mEq/liter; potas-
sium, 6.9 mEq/liter; chloride, 119 mEq/liter; total carbon dioxide, 8
mM/liter; urea nitrogen, 57 mg/dl; serum creatinine, 4.4 mg/dl; calcium,
8.4 mg/dl; and phosphorus, 7.3 mg/dl. The hemoglobin was 3.7 g/dl;
hematocrit, 11.5%; and white blood cell count, 12,500 mm3 with 6%
eosinophils. Many sickled red blood cells, moderate ovalocytes, How-
ell-Jolly bodies, and nucleated red blood cells were present on blood
smear. An arterial blood gas evaluation disclosed: pH, 7.23; pCO2, 21
mm Hg; pO2' 99 mm Hg; and calculated bicarbonate, 8 mEq/liter. An
electrocardiogram demonstrated sinus bradycardia and symmetrically
peaked T-waves. Urinalysis revealed: pH, 5.0; protein, 30 mg/dl; 10—15
white blood cells and 3—6 red blood cells/high-power field. A Hansen's
stain of the urinary sediment disclosed rare eosinophils. Measurement
of chemistry values on a random sample of urine obtained shortly after
admission demonstrated: sodium, 66 mEq/liter; potassium, 10 mEq/
liter; chloride, 53 mEq/liter; and creatinine, 77 mg/dl. Negative studies
included Urine culture for routine pathogens and acid-fast bacilli, and
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Fig 1. Intramitochondrial pathways for renal
glutamine metabolism. Abbreviated terms
enclosed in boxes refer to the enzymes
glutaminase (PDG), glutamate dehydrogenase
(GDH), glutamate oxaloacetate transaminase
(GOT), a-ketoglutarate dehydrogenase
(aKGDH), and succinate dehydrogenase
(SDH). Transporters are denoted by ovals on
the membrane (clockwise beginning at left):
the glutamine transporter, dicarboxylate
carrier, the glutamate/aspartate antiporter, and
the glutamate/hydroxyl carrier. + =
stimulation; — = inhibition. Dark arrows refer
to sites activated at acid medium pH.
(Modified from Ref. 52).
serum HIV antibody titer. A renal ultrasound disclosed 11 cm kidneys
without hydronephrosis.
The patient was treated with nebulized albuterol, intravenous glucose
and insulin, sodium bicarbonate, and four units of packed red blood
cells. A protein- and potassium-restricted diet, oral sodium bicarbon-
ate, aluminum hydroxide, nifedipine, and clonidine were prescribed.
With this regimen, both his clinical status and his laboratory values
improved. Nine days after admission, laboratory values were: plasma
sodium, 141 mEq/liter; potassium, 5.2 mEq/liter; chloride, Ill mEq/
liter; total carbon dioxide, 16 mM/liter; urea nitrogen, 36 mg/dl; and
serum creatinine, 3.4 mg/dl. A 24-hour urine collection contained 0.63 g
protein, 1115 mg creatinine, and 34.7 mEq ammonium. Creatinine
clearance was 23 mI/mm. Repeated urine sediment examinations dis-
closed 3—b white blood cells, 5-.-l0 red blood cells, and occasional
granular casts/high-power field. The patient declined further diagnostic
studies and was discharged with followup in the Renal Clinic.
Discussion
DR. ANTON C. SCHOOLWERTH (Chairman, Division of
Nephrology, Medical College of Virginia Hospitals, and Pro-
fessor of Medicine and Physiology, Virginia Commonwealth
University, Richmond, Virginia): Despite recent controversy, it
is generally accepted that the kidney plays a primary role in
maintaining acid-base homeostasis [1, 2J. The kidney can syn-
thesize bicarbonate; this process is closely linked to the metab-
olism of glutamine, the primary precursor of ammonium. Both
ammonium excretion and the metabolism within the renal
cortex of the carbon skeleton of glutamine, in the form of
cr-ketoglutarate (aKG), are necessary for net bicarbonate syn-
thesis [1, 3]. The escape of ammonium by renal excretion,
rather than its addition to renal venous blood, is critical in
preventing ammonium incorporation into urea by the liver,
because ureagenesis, which is a bicarbonate-consuming pro-
cess, would counteract bicarbonate synthesis by the kidney [1,
3, 4, 5]. The metabolism of the glutamine carbon skeleton,
either to glucose or to carbon dioxide and water, is critical,
because two hydrogen ions are consumed per one glutamine
utilized [1, 3]. A great deal of work has been directed at
understanding the regulation of renal ammoniagenesis because
of the kidney's remarkable ability to increase ammonium syn-
thesis substantially in response to metabolic acidosis. Studies in
this area have focused on the relationship between the biochem-
istry of glutamine metabolism and the transport of metabolites
into and out of renal cortical mitochondria, where most of the
key enzymes related to glutamine metabolism are located [6, 7].
In this presentation I will emphasize the current status of our
understanding of the stimulation of ammonium formation in
response to metabolic acidosis. In addition, I will review recent
data suggesting that the increased rate of ammonium synthesis
per nephron might contribute to nephron destruction in exper-
imental renal disease. Finally, I will mention briefly recent
observations suggesting that altered animonium synthesis and
handling underlie the pathogenesis of distal renal tubular aci-
dosis. The relative contributions of the kidney and liver to the
maintenance of acid-base homeostasis have been addressed
elsewhere [4, 8—12], and I will not discuss these issues here.
The problems that remain to be resolved include the follow-
ing: (1) the details of the pathways of renal glutamine metabo-
lism; (2) the specific site(s) at which augmented rates of renal
ammoniagensis are regulated in acute and chronic metabolic
acidosis; and (3) factors that modulate ammonium synthesis.
Although several pathways exist by which glutamine might be
metabolized to yield ammonium in renal cortex, the pathway
involving the enzymes glutaminase and glutamate dehydroge-
nase is generally accepted as the predominant one [1, 13].
Glutamine is deamidated by phosphate-dependent glutaminase
(PDG) to yield ammonium and glutamate. Oxidative deamina-
tion of the resulting glutamate by glutamate dehydrogenase
(GDH) then yields ammonium and a-ketoglutarate. These two
enzymes, which together comprise the glutaminase/glutamate
dehydrogenase pathway, are located in the mitochondrial ma-
trix space (Fig, 1) and are found in distal and proximal convo-
luted tubules (PCT) in the rat [14, 15]. However, in chronic
metabolic acidosis, both enzyme activities increase substan-
tially (5- to 20-fold) only in the S1 and S2 segments of PCT [14,
15]. These findings correlate well with measurements of ammo-
nium production by microdissected nephron segments from
control and acidotic rats incubated in vitro with glutamine [16,
17].
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Other pathways of glutamine metabolism, studied most ex-
tensively in the rat, do not appear to have a significant physio-
logic role in ammoniagenesis. For example, y-glutamyl trans-
peptidase, although capable of forming ammonium from
glutamine, is unlikely to be important. Located in the brush-
border membrane of the S3 segment of the PCT, this enzyme
has its active site exposed to the luminal surface [18]. Glu-
tamine is removed almost completely from glomerular filtrate in
the early PCT segments (S1 and S2), however, so no substrate is
available (to the enzyme) for ammonium formation unless
glutamine is secreted into the lumen in this or more proximal
PCT segments. Such secretion seems unlikely. Additional path-
ways, including the cytosolic glutaminase II pathway and the
purine nucleotide cycle, probably do not contribute substan-
tially to renal ammonium formation either [1, 2, 19—211.
Some issues with regard to pathways of ammonium formation
remain unresolved. For example, it has not been demonstrated
conclusively that the rat kidney extracts glutamine under phys-
iologic conditions [22, 23]. Thus, although glutamine extraction
increases markedly in metabolic acidosis [22, 23], the precursor
for ammonium formation under basal conditions remains to be
clarified. The source of increased synthesis of ammonium by
human kidney in acute metabolic acidosis also has not been
identified. Tizianello and coworkers found no change in renal
glutamine extraction under these conditions and raised the ques-
tion of whether other sources of ammonium are significant [24].
More controversial than the arguments regarding the path-
way of ammonium formation is the site of regulation of glu-
tamine metabolism both in acute and chronic metabolic acido-
sis. I believe, however, that arguments regarding this issue are
more apparent than real. If one accepts that regulation is likely
to be different in acute, as opposed to chronic, acidosis, that
significant species differences exist, and that numerous poten-
tial sites of control are present, there actually might be consid-
erable agreement in this area. Although many investigators
have advanced hypotheses focusing on one specific site of
regulation, it is probable, as Pitts suggested, that several sites
act in concert to control the accelerated rate of glutamine
metabolism in metabolic acidosis [25]. I believe that a lack of
appreciation of species differences and a tendency to extrapo-
late results from one species to another have confounded a full
understanding of the regulation of renal ammoniagenesis. At
present, it seems likely that several control sites exist and that
the relative importance of these control sites varies in different
species, as I will discuss later.
Finally, the mechanisms by which several factors, including
ions and hormones, modulate renal ammonium production
require clarification, as reviewed by Tannen and Sahai [13].
Later I will discuss some of these factors, which include potas-
sium, calcium, cyclic nucleotides, angiotensin II, catecholamines,
parathyroid hormone, insulin, and growth hormone.
Acute metabolic acidosis: In discussing metabolic acidosis
(both acute and chronic), I will separate my comments on data
obtained in the rat from those obtained in the dog, because
substantial species differences have been demonstrated. In the
rat, an acute acid load results in marked changes in renal
cortical metabolite levels [26, 27]. The most consistent of these
changes is a decrease in aKG content of as much as 50% [261.
Subsequent experiments, based on findings in other tissues [28],
have demonstrated that increased hydrogen ion activity acti-
yates renal cortical a-ketoglutarate dehydrogenase (aKGDH)
[29—31]. Lowry and Ross first showed that increased hydrogen
ion activity decreases the Km of the enzyme for aKG [29].
These findings, subsequently confirmed in our laboratory [32,
33], explain the observation of increased aKG oxidation and
calculated flux through SKGDH by intact renal cortical mito-
chondria at acid pH [30, 31]. The result of an increase in
hydrogen ion activity on aKGDH is a decrease in mitochondrial
matrix aKG content with a consequent increase in glutamate
deamination and ammonium formation by GDH [31, 34]. De-
creased matrix aKG can accelerate glutamate deamination
either by decreasing the reverse reaction (that is, aKG amina-
tion) of GDH or by relieving competitive inhibition by aKG on
glutamate deamination [32]. Indeed, in-vitro studies indicate
that accelerated GDH flux is the first event leading to increased
ammonium synthesis in the presence of acidification of the
medium [31, 34]. Thus, with the exception of data recently
reported by Bogusky and Dietrich [35], the results from several
laboratories indicate that acute acidosis in the rat accelerates
flux through aKGDH with a resultant increase in ammonium
formation by the GDH reaction (Fig. 1) [20, 30, 31]. These
findings imply that glutamate deamination precedes increased
flux through PDG in acute acidosis, as suggested 20 years ago
by Preuss and Weiss [36]. However, Preuss postulated that
GDH flux was increased in acidosis by a more oxidized mito-
chondrial redox state [37], for which no direct evidence is
available. Although the precise timing of subsequent PDG
activation remains to be elucidated, it is likely that with
continued increase in GDH flux, matrix glutamate levels de-
crease. Glutamate is a well-recognized end-product inhibitor of
renal PDG [38]; this change therefore might account for PDG
activation via an allosteric effect.
These data suggest that an early event in acute acidosis is
activation of aKGDH consequent to an increase in hydrogen
ion activity. Because aKGDH is a mitochondrial enzyme, it
should respond in situ to altered hydrogen ion activity within
the matrix space. The significance of the findings with the
solubilized enzyme and intact mitochondria [29, 31, 33] could
not be interpreted until further data were available that would
allow one to estimate the change in mitochrondrial matrix pH
(PHm) in intact PCT in response to altered extracellular fluid
(ECF) pH. As predicted by Mitchell's chemiosmotic hypothesis
[39], the mitochondrial matrix space is likely alkaline with
respect to the extramitochondrial medium; the latter should
simulate the cytosolic space. This prediction was confirmed
experimentally in isolated mitochondria from several tissues [7,
8, 40] by the calculation of steady-state PHm from the distribu-
tion of the labeled organic anion 5,5-dimethyloxazolidine-2,4-
dione (DM0). This method, suitable for estimating steady-state
PHm values, assumes that: (1) the un-ionized DM0 species
readily permeates the inner mitochondrial membrane, and (2)
the distribution of the anionic species is determined by the
prevailing pH in the intra- and extramitochondrial spaces [41].
Using this DM0 method, we studied rat kidneys in bicarbonate-
free media and found pH to be 7.9 at medium pH 7.3; the pH
gradient (pH) was approximately 0.6 pH units [31]. An obser-
vation first made by Simpson and Hager and not yet explained
is that the pH is approximately 0.2 pH units lower when
determined in bicarbonate-buffered media [42, 43]. Neverthe-
less, regardless of the buffer sytem utilized, these in-vitro
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PHea pH1 PHm APHm
Non-HC03 (7)b 7.03 O.01'
7.41 0.01
7.70 0.01
6.89 0.03
7.08 0.02
7.30 0.03
7.65 0.03
7.96 0.08
8.37 0.03
0.78 0.09
0.88 0.09
1.15 0,03
HC03 (12) 7.04 0.01
7.44 0.01
7.73 0.01
6.91 0.02
7.10 0.03
7.28 0,02
7.51 0.08
7.78 0.06
8.08 0.08
0.62 0.03
0.68 0.08
0.79 0.05
studies with isolated mitochondria indicate that the matrix
space is more alkaline than the medium, which suggests that
P1m is more alkaline than the cytosolic pH in situ. These
studies also indicated that medium acidification in vitro caused
PHm to decrease only slightly with a resultant increase in the
pH [31, 43].
To obtain additional data regarding the change in PHm that
occurs in situ in response to a decrease in ECF pH, we adapted
a technique used in isolated hepatocytes [441 to estimate
simultaneously changes in cytosolic and mitochondrial matrix
pH in suspensions of intact rat proximal tubules as a function of
altered pH of the medium [4511. These experiments were per-
formed with the fluorescent probe 2' ,7'-biscarboxyethyl-
5(6)carboxyfluorescein (BCECF) to estimate intracellular pH
[461. Using BCECF in combination with radiolabeled DM0,
which distributes across both the plasma and mitochondrial
membranes, one can calculate matrix pH if the percentage of
PCT occupied by the matrix space is known; the latter was
determined by us [45] and others [47] to be approximately 20%.
Using this technique, we estimated steady-state cytosolic pH
(pH1) and PHm at different ECF pH (pHe) values [45]. The data,
obtained with bicarbonate-buffered media and summarized in
Table 1 and Figure 2, indicate a linear relationship between PHe
and pH1 as well as between pH1 and PHm. We observed no
difference in pH1 in the absence of bicarbonate as buffer;
however, as in isolated mitochondria, we found pHm to be
approximately 0.2 pH units lower in the presence of bicarbon-
ate as compared with its absence [45]. These findings indicate
that the acceleration in aKGDH flux that occurs in intact
proximal nephron segments in acute metabolic acidosis might
simply reflect the ability of these segments to respond to a
decrease in PTe and thus cause a decrease in PHm. However,
the decreases in pHm, although related linearly to those in the
pH and pH1, are relatively small. It remains uncertain whether
this change in PHm can fully explain the activation of aKGDH
or whether the concentration of other ions, such as Ca2, which
is also known to activate aKGDH [29, 48—SO], changes in the
matrix space in acute acidosis and contributes to this activation.
The effects of a change in pH,, on pH1 and P11m in the rat are
quite different from those in the dog [51, 52], as shown in Figure
3. At all levels of pH,,, we found that pH, was higher in proximal
I I I I I
6.6 6.8 7.0 7.2 7.4 7.6
pH,
Fig. 2. Relationship of cytosolic pH (pH,) and the medium pH (pJ1)
(top panel) and of mitochondrial matrix pH (pH,,,) and pH1 in rat
pro..mal tubules. Symbols indicate that tubules were incubated in
nonbicarbonate (non HCO31- or bicarbonate (HCO3 i-buffered media.
(Modified from Ref. 45).
nephron segments obtained from dog than in those obtained
from rat [51, 52]. Moreover, in contrast to the rat, PHm appears
to be well buffered in dog and remained unchanged (PHm
approximately 7.9) over the PF1e range 7.0—7.7. Thus, no
decrease in pHm, which could account for activation of
aKGDH, apparently occurs with acidification of PH,, in the dog.
Although it is not entirely certain that ammonium production is
increased in acute metabolic acidosis in the dog in vivo [26, 53],
this uncertainty might relate to the decrease in GFR and renal
blood flow accompanying an acute intravenous infusion of
hydrochloric acid. These hemodynamic changes might lower
renal glutamine delivery and offset any increase in glutamine
metabolism such that calculated total-kidney ammonium forma-
tion is similar in acute metabolic acidosis compared with the
control situation [53]. Other data, obtained in in-vitro studies in
our laboratory, do suggest a pH effect on glutamine metabolism
in canine renal tubules and indicate substantial differences in
mitochondrial response to pH changes in the dog compared
Table 1. Effect of medium pH changes on cytosolic and
mitochondrial pH and the pH gradient across the inner
mitochondrial membrane
a Cytosolic pH (pH,) and mitochondrial pH (pH,,,) were determined at
different medium pH (PHe) values in intact rat renal cortical tubules.b Number of experiments is shown in parentheses. Experiments were
performed with nonbicarbonate (non-HCO3i- or bicarbonate
(HC03)-buffered media. The non-HC03 buffer used was HEPES.
C The results (modified from Ref. 45) are expressed as mean 5EM.
7.6 - • nonHCO3
0 HCO
6.8 07!2747!67!8
pH
0.
EI0.
8.4
8.2
8.0
7.8 -
7.6 -
7.4 -
• nonHCO3 •
o HCoç
.
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a
• Dog
.2tI7.2
7.0.
6.8- I
7.0 7.2 7.4 7.6 7.8
pH
8.2 -
• Dog
o Rat
8.0 -
7.8-a
7.6
7.4
6.8 7.0 7.2 7.4 7.6
pH
PHe
Fig. 3. Effect of changes in pH on pH1, pH,,,, and the pH gradient
across the mitochondrial membrane (zpH) in proximal tubules from rat
and dog renal cortex. (Modified from Ref. 52).
with the rat [51, 52]. Although tubules from canine renal cortex
respond to acidification of the medium with an increase in
ammonium synthesis from glutamine, this increase appears to
0
NH4 PDG GDH
Fig. 4. Ammonium (NH4) production by proximal tubules (top panel)
and isolated mitochondria (bottom panel) from control and chronically
acidotic dogs. In the top panel, the effect of medium pH (pH) was
evaluated. In the bottom panel, the contribution of flux through
glutaminase (PDG) and glutamate dehydrogenase (GDH) to NH4
formation is shown. k, significantly greater than control, P < .05.
Substrate = 1 mM glutamine. (Modified from Ref. 51.)
be almost entirely due to augmented flux of PDG, not GDH
(Fig. 4) [51, 52].
An abundance of additional data indicates the complexity
surrounding glutamine and glutamate metabolism in rat renal
cortex. These data have emphasized the close relationship
between transport of metabolites across the inner mitochondrial
membrane and flux through enzymes located within the matrix
space [8, 54]. As Figure 2 shows, several transporters regulate
glutamate transport across the inner mitochondrial membrane.
7.6
E0
C',
C)
E
0
EC
20 —
15 —
C)
E
10 —
E
0
EC
5—
7.0 7.4 7.7
pH,,
1.0
0.8
Control
Acidosis
*
I
0.4
0.2
7.0 7.2 7.4 7.6 7.8
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These transporters, also found in mitochondria from extrarenal
tissues, include the so-called glutamate hydroxyl transporter
and the glutamate/aspartate antiporter [7, 54]. I would like to
review briefly the characteristics of these transporters. The
electroneutral glutamate hydroxyl carrier is believed to trans-
port glutamate with H; glutamate entering mitochondria on
this carrier is functionally linked to metabolism by GDH. This
transporter is relatively inactive in kidney with a max (3
nmol . min . mg protein') one order of magnitude lower
than in liver [55, 56]. Moreover, in contrast to liver, the activity
of this transporter is not stimulated when the medium is
acidified [55, 56]. In fact, data indicate that an insufficient
amount of glutamate enters renal mitochondria on the glutamate
hydroxyl carrier to result in substantial glutamate deamination
by GDH [55, 57, 58]. Only glutamate formed from glutamine
within the matrix space can be deaminated to a significant
degree under physiologic conditions [58]. Although glutamate
uptake on this carrier is very slow in the kidney, the glutamate
hydroxyl transporter might exert some effect on matrix gluta-
mate content and hence GDH flux, since efflux of glutamate
from the matrix space on this carrier is pH sensitive [59].
Studies from our laboratory have demonstrated that effiux of
glutamate on this transporter, which obeys first-order kinetics
with respect to glutamate concentration, is decreased in an
acidic medium [591. The decrease in glutamate effiux under
these conditions could contribute to accelerated GDH flux; the
resultant increase in matrix glutamate concentration (coupled
with a decrease in cKG) would increase the matrix ratio of
glutamate:aKG and drive the GDH reaction in the direction of
increased glutamate deamination [31].
The other glutamate transporter is an electrogenic glutamate!
aspartate countertransporter [60]. Glutamate, entering mito-
chondria in exchange for aspartate, is transaminated by mito-
chondrial aspartate aminotrnsferase (GOT) in a reaction that
produces no ammonium. But because aKG is one of the
products of the GOT reaction, this carrier can influence ammo-
nium formation. Increased glutamate/aspartate carrier activity
with the resultant increased flux through GOT can reduce
ammonium formation consequent to aKG inhibition of GDH
flux. Support for this concept comes from studies utilizing
transaminase inhibitors. For example, in the presence of ami-
nooxyacetate, an inhibitor of GOT, ammonium formation by
GDH increases in isolated rat mitochondria [61]. This effect of
aminooxyacetate is due to a decrease in aKG formation [61].
Although the response of the glutamate!aspartate carrier to
acute acidosis in situ is not known, its activity is likely reduced
and, together with a stimulation of aKGDH flux, this transport
system probably contributes to the observed stimulation in
GDH flux.
Adam and Simpson postulated a major role for the transport
of glutamine across the inner mitochondrial membrane as a
rate-controlling step in glutamine metabolism in acidosis [62].
They incubated rat and dog renal cortical mitochondria with
radiolabeled glutamine in the presence of rotenone, which
inhibited glutamate metabolism, and demonstrated increased
uptake of glutamine and its conversion to glutamate when the
pH of the medium was decreased from 7.4 to 7.0 [62—64].
Although rotenone prevents glutamate metabolism, it does not
inhibit PDG. Thus, these studies [62, 631 and those by others
[65—67] could not unequivocally distinguish activation of glu-
tamine transport from its deamidation by PDG. Recently,
Sastrasinh and Sastrasinh attempted to clarify this issue by
studying the transport of labeled glutamine in submitochondrial
particles (SMP), which are largely free of contaminating PDG
[68, 69]. Using SMP, these investigators demonstrated a higher
rate of glutamine uptake at medium pH 7.0 compared with 7.4;
these findings are compatible with an activation of the glu-
tamine transporter in acute acidosis. Sastrasinh and Sastrasinh
suggested that a decrease in the pH of the medium reduced the
Km of the transporter for glutamine [69]. Although these data
indicate a role for accelerated glutamine transport across the
inner membrane of dog and rat renal mitochondria in acute
acidosis, further studies are needed to clarify and fully charac-
terize the kinetics of this transporter. The data from Simpson
and colleagues suggest that the glutamine transporter is partic-
ularly important in the augmented rate of ammoniagenesis in
chronic metabolic acidosis [7, 62, 63, see later]. No studies are
available to assess this carrier in human kidneys.
One additional site of potential regulation is the succinate
dehydrogenase (SDH) step (see Fig. 1). As described initially in
hepatic [701 and more recently in renal mitochondria [71], the
activity of this enzyme is inhibited competitively by bicarbon-
ate ions with a K3 of approximately 12 mM. If this effect is
present in situ, a decrease in bicarbonate content in the matrix
space could activate SDH and complement the effect of de-
creased pH on aKGDH, thereby resulting in an increase in
ammonium production by GDH. Improved understanding of
this regulatory site will require data on the prevailing range of
matrix bicarbonate concentrations under both control and aci-
dotic conditions. However, this bicarbonate-sensitive site of
regulation could explain the observation made by Rodriguez-
Nichols et al that ammonium synthesis is not increased in
chronic respiratory acidosis [72]. Ammonium production and
excretion are increased acutely in respiratory acidosis, presum-
ably in response to a decrease in intracellular pH. With persis-
tence of hypercapnea, this leads to an increase in bicarbonate
content in extracellular fluid and the matrix space in renal
mitochondria. The increase in matrix bicarbonate, by inhibiting
sDH, could in turn prevent a sustained increase in glutamine
metabolism (brought about by an acid pH) from occurring.
In summary, data indicate that in the rat, ammonium forma-
tion is accelerated in acute acidosis primarily by an increase in
flux through GDH, consequent to a decrease in matrix aKG
content; glutamine transport also might be increased under
these conditions. In the dog, acidification of P1e leads to a
modest increase in ammonium synthesis, at least in vitro, due
primarily to an increase in glutamine transport and deamidation
by PDG. Further studies are needed, particularly in the dog, to
unravel the factors that contribute to the increased rate of
glutamine metabolism in acute acidosis. In addition, further
information is needed to characterize the mechanisms of in-
creased ammonium production in acute acidosis in human
kidneys.
Chronic metabolic acidosis. That increase in ammonium
excretion observed in chronic metabolic acidosis is associated
with activation of PDG and GDH in rat renal cortex has been
recognized for almost 40 years [731. Since then, we have
learned that the increase in enzyme activity occurs exclusively
in the early segments of PCT [14, 15]. Studies both with isolated
rat renal mitochondria [57, 74] and isolated tubules [75] have
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indicated that augmented flux through both PDG and GDH
accounts for the increased ammonium synthesized in chronic
metabolic acidosis. The mechanisms and precise stimulus ac-
counting for the augmented flux rates have not been determined
unequivocally. Evidence supports an increase in glutamine
transport in chronic metabolic acidosis [62—64] secondary to an
increase in ''max of the transporter. An increase in Vmax
suggests an increase in the number of transport sites, in turn
due to an increase in synthesis, reduction in turnover, or
unmasking of carrier molecules on the inner mitochondrial
membrane [7]. However, recent data using SMP from acidotic
rats demonstrated a slight decrease from control in Km for
glutamine but no increase from control in Vmax of glutamine
transport [68]; thus, the mechanism of an increased rate of
glutamine transport in metabolic acidosis remains to be clari-
fied. Since an increase in GDH flux accounts for as much as
50% of the rise in ammonium formation [74], other factors such
as accelerated aKGDH flux could be critical in chronic acido-
sis, as in acute metabolic acidosis [29—31].
In the rat, renal glucose production is also accelerated in
response to metabolic acidosis. Goodman et al suggested 25
years ago that stimulation of gluconeogenesis might regulate
glutamine metabolism [76]. They proposed that the key gluco-
neogenic enzyme, phosphoenolpyruvate carboxykinase
(PEPCK), was induced early in acidosis and led to an increase
in glucose formation; as a result of the increased rate of glucose
synthesis, renal cortical glutamate content decreased with
subsequent activation of PDG [77]. Although more recent data
have demonstrated that an increase in glucose synthesis is not
a necessary step for augmented ammoniagenesis, gene expres-
sion of PEPCK as well as PDG have been studied in response to
acidification [78—83]. Curthoys and associates have demon-
strated an increase in messenger RNA for PDG and PEPCK,
changes that precede the increase in assayable enzyme activity
in rat PCT and in cultured LLC-PK1 F cells [78—80, 83].
Because the message for both enzymes increased in response to
acidification of the medium, the data suggest that the induction
of mRNAs for these enzymes might be mediated by a common
signal transduction mechanism [80]. The data also indicate
separate regulation of gene expression of both enzymes by W
and bicarbonate. Further studies are necessary to characterize
the mechanisms by which acidosis affects gene expression in rat
renal cortex.
One of the major differences between rat and dog is that
chronic metabolic acidosis in the dog accelerates the rate of
renal ammonium excretion without an evident increase in PDG
or GDH enzyme activities [841. These observations, made more
than 30 years ago, suggest that these enzymes are not induced
in the canine kidney, and that the stimulation of ammoniagene-
sis cannot be ascribed to an increased amount of PDG and
GDH. Indeed, Halperin and coworkers have suggested that an
excess of both enzymes is present in renal cortex in the rat and
the dog [2]; one can presume that factors other than the amount
of enzyme are of greater importance in leading to an augmented
rate of glutamine metabolism in acidosis. As far as I am aware,
no studies have been published evaluating the effect of meta-
bolic acidosis on the message for PDG and GDH and the
mechanism(s) regulating ammonium synthesis in dog renal
cortex. This evaluation is important because the dog model
most closely approximates the systems likely to exist in human
kidney [85]. The data on canine renal ammoniagenesis have
been reviewed by Vinay et al [53], who have performed most of
the critical experiments. Their data, which involve studies
performed in vivo, suggest activation in metabolic acidosis of
the mitochondrial glutaminase/glutamate dehydrogenase path-
way [53]. However, recent in-vitro studies with isolated mito-
chondria from acidotic canine renal cortex have demonstrated
that an increase in PDG, but not GDH, flux accounts for the
increased ammonium production [51, 52].
One additional difference has been noted between dog and
rat. The rat proximal tubule, but not that of the dog or the
human, contains the enzyme glutamine synthetase (GS), which
catalyzes the formation of glutamine from glutamate and am-
monium [85]. The function of this enzyme in the rodent kidney
is not clear, although it possibly is more critical for the smaller
species if substantial glutamine losses are to be prevented,
especially under physiologic conditions.
Although Tannen and Sahai have addressed other modulating
factors of renal ammoniagenesis [13], 1 would like to mention
briefly some additional points. Recently, interest has been
rekindled in evaluating the role of Ca2 in affecting both renal
gluconeogenesis and ammoniagenesis, particularly with the
demonstration by Denton and McCormack that submicromolar
concentrations of Ca2 stimulate the activity of aKGDH,
pyruvate dehydrogenase, and isocitrate dehydrogenase [50, 86].
Estimates indicate that changes in mitochondrial free Ca2 are
likely to be in a range that could regulate the activity of these
enzymes in situ [87, 88]. It will be of interest to determine
matrix-free Ca2 alterations as a function of acid-base distur-
bances; for example, in metabolic acidosis, an increase could
occur. These studies might shed light on the different behavior
of rat and dog renal cortex in response to acute acidosis. In
addition, studies are needed to determine whether the hormonal
stimulation of gluconeogenesis and ammoniagenesis is medi-
ated by increases in cytosolic and mitochondrial free Ca2t
Reports from several laboratories have indicated that angioten-
sin II, a-adrenergic agonists, parathyroid hormone, and dopa-
mine stimulate both of these metabolic processes, whereas
insulin stimulates ammonium but inhibits glucose production
[89—94]. Furthermore, we have noted a relationship between the
hormonal stimulation of ammoniagenesis and the activity of the
luminal Na/H exchanger in PCT [94]. Specifically, stimula-
tion of metabolism by hormones that activate the Na/H
exchanger (angiotensin II, a-agonists) may do so by a different
mechanism than hormones that inhibit the exchanger (parathy-
roid hormone, dopamine) [95]. Moreover, in the case of the
former agents, stimulation of Na/H exchange might be
necessary to achieve maximal metabolic stimulation, as the
stimulation of ammoniagenesis by angiotensin II and a1-ago-
nists, but not parathyroid hormone and dopamine, is prevented
by the specific inhibitor of luminal Na/H exchange, ethyliso-
propyl amiloride [95]. Further work defining this interaction
also might provide more information about the subcellular
messenger systems that modulate hormonal effects of ammo-
niagenesis.
The classic studies by Bricker and associates demonstrated
an adaptive increase in ammonium excretion per nephron in the
remnant canine kidney [96]. This report prompted Simpson to
suggest that similar changes are likely to occur in humans [97].
These findings were extended to studies in the remnant rat
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kidney [98, 99], which also provided evidence for increased
in-vitro ammonium production per gram and per cell in the
remaining tissue [98]. More recently, Harris et al have sug-
gested that hypermetabolism occurs in the remnant rat kidney
[100]. This adaptive response may prevent severe metabolic
acidosis from occurring early in the course of progressive renal
disease, even though progressive reduction in renal mass ulti-
mately limits ammonium production and results in the well-
recognized metabolic acidosis of chronic renal failure. Nath and
colleagues have suggested that the adaptive increase in ammo-
niagenesis per nephron could have adverse consequences [101],
In an elegant series of experiments, they demonstrated that
ammonia can activate the alternate complement pathway by
amidation and that this activation could lead to tissue injury in
the form of tubulointerstitial disease [101]. In these studies,
they demonstrated that suppressing ammonium formation by
sodium bicarbonate feeding reduced the degree of tubulo-
interstitial damage in rats following subtotal nephrectomy. The
same group proposed that hypermetabolism is deleterious be-
cause of the formation of reactive oxygen species [102]. Al-
though these are attractive hypotheses, further work is neces-
sary to confirm their relevance and validity to the situation in
vivo. For example, Buerkert et al have estimated that the
concentration of ammonium in renal cortex of the remnant rat
kidney is twofold higher than in controls [103]: whether these
levels are sufficient to explain an activation of the complement
pathway in renal tissue in vivo has not been confirmed. The
issue is made even more interesting by the recent observation
by Golchini and coworkers that ammonium chloride induces
hypertrophy in cultured proximal tubule cells [104].
Do altered proximal tubular glutamine metabolism and am-
monium formation play a role in the pathogenesis of distal renal
tubular acidosis? Recently, two new hypotheses have been
developed to explain this condition [105, 106]. Donnelly and
associates have suggested that distal renal tubular acidosis is
the consequence of a decreased pH, in the PCT [105]. Stimu-
lated ammonium formation secondary to acidification of the
proximal tubular cell may lead to toxicity in the medulla due to
high ammonia content, as well as to nephrolithiasis and neph-
rocalcinosis from the decreased urinary citrate excretion [106].
Kurtz et al have postulated that some forms of distal renal
tubular acidosis can occur secondary to altered permeability to
ammonia and/or NH4 in the collecting duct [104]. They
proposed that ammonium enters the renal venous circulation,
rather than the tubular fluid and urine; as a result of the
subsequent incorporation of this ammonium into urea by the
liver, the consumption of bicarbonate would be increased [105].
Further work is necessary to test the validity of these hypoth-
eses. However, both theses emphasize the point made recently
by Halperin et al that a reduction in urine ammonium excretion
is the key feature of distal renal tubular acidosis [107].
In this review I have attempted to summarize our current
understanding of the renal regulation of ammonium formation.
Although considerable progress has been made over the last 40
years, key issues remain unresolved and require further inves-
tigation. This challenge is complicated by substantial species
differences and by the likelihood that controlling factors are
different in acute, as opposed to chronic, acidosis. The appli-
cation of contemporary techniques of molecular biology to this
problem should provide important new insights into the effects
of acidosis on the genetic regulation of ammonium metabolism.
Questions and answers
Da. NTCOLAOS E. MADIAS (Chief, Division of Nephrology,
New England Medical Center, Boston, Massachusetts): I'd like
to ask you to briefly address the issue of potassium's effect on
ammonium generation and also the possibility that increased
ammonium production might have a role in the pathogenesis of
the nephropathy of potassium depletion.
DR. SCHOOLWERTH: Potassium depletion has been clearly
shown to stimulate renal ammonium production [108]. Although
the signal responsible for stimulating and maintaining increased
ammonium generation has not been elucidated, the suggestion
that intracellular acidosis in the kidney occurs as a consequence
of potassium depletion is supported by some, but not all, data
[109, 110]. Regardless of the mechanism, several clinical con-
sequences have been postulated. For example, renal ammo-
nium production, with diversion into the systemic circulation,
might contribute to the development of hepatic coma in patients
with liver disease and potassium depletion [111]. Recently
Tolins et al have suggested that the pathogenesis of hypokale-
mic nephropathy involves activation of the alternate comple-
ment pathway by increased renal cortical ammonia levels with
subsequent development of tubulointerstitial disease [112].
DR. JOHN T. HARRINGTON (Chief of Medicine, Newton-
Wellesley Hospital, Newton, Massachusetts): You referred to
studies on the kinetics of alpha ketoglutarate at specific pHs of
7.4 and pH 6.8, I believe. Have you or others done studies at
other pHs to determine whether the relationship is a step
function or a graded function?
DR. SCHOOLWERTH: Lowry and Ross studied the kinetics of
renal aKGDH over the range 7.7 to 6.8 [29]. They demonstrated
a reduction in the Km of the enzyme for aKG with each 0.3 pH
unit decrease, suggesting that the relationship is a graded one.
This finding is compatible with our observations on the effect of
pH on cKG oxidation by intact renal mitochondria.
DR. HARRTNGTON: My second question is more complicated,
but it is based on my being a believer in the 'non-homeostatic"
control of systemic pH [113, 114]. More than 20 years ago,
studies from the Renal Laboratory here at the New England
Medical Center showed that the administration of ADH and
water to dogs in a steady state of chronic HCI acidosis raised
serum bicarbonate to normal and increased renal net acid
excretion sufficiently to account for that rise [115]. My question
is: Are there enzymatic studies comparable to yours in the kind
of experimental setting I described?
DR. SCHOOLWERTH: Do you mean when water excretion was
decreased?
DR. HARRINCTON: In effect, the animals developed SIADH.
Later studies disclosed increased aldosterone excretion in the
presence of volume expansion [1161.
DR. SCHOOLWERTH: I am not aware of any enzymatic studies
that would explain these observations. However, the experi-
mental maneuvers performed in the studies you described were
complex. No specific data on ammonium production and excre-
tion were given, although it is likely that ammonium production
was stimulated. It should be noted that following vasopressin
administration, the dogs became hypokalemic [115]. Thus the
hypokalemia, resulting from vasopressin administration, could
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have increased ammonium production beyond that occurring in
the stable state of metabolic acidosis. Despite volume expan-
sion and hypokalemia, aldosterone secretion and excretion
were increased, as you pointed out; this increase might contrib-
ute to an increased diversion of ammonium into the urine [1161.
Recently, Halperin and Chen, using a different protocol, dem-
onstrated that hypotonic volume expansion in chronically aci-
dotic dogs markedly increased urine flow rate; this increase also
could contribute to the increased diversion of generated ammo-
nium into the urine [1171. In the dogs with a serum sodium
concentration of 126 mmol/liter, but without hypokalemia, the
rate of renal ammonium generation was not increased during
hyponatremia. Thus, I would speculate that the major factor
producing increased net acid excretion in the original studies by
Lowance et a! was hypokalemia, and that the increased urine
flow rate and aldosterone secretion resulted in an increased rate
of ammonium production and excretion.
DR. MADIAS: The study that Dr. Harrington referred to
showed that administration of vasopressin during restriction of
water intake (thus preventing fluid retention) did not increase
renal acid excretion or plasma bicarbonate concentration. Hy-
potonic volume expansion was required for the renal correction
of the metabolic acidosis.
DR. SCHOOLWERTH: Vasopressin administration in acidotic
dogs that are water restricted resulted in little further change in
serum potassium concentration [115]. In addition, although
these data were not provided, it is likely that urine flow rate was
less than that in the animals allowed unrestricted water intake.
Finally, aldosterone secretion did not increase with administra-
tion of vasopressin during water restriction [1161. The mecha-
nism for increased aldosterone secretion remains obscure.
DR. ANDREW S. LEVEY (Division of Nephrology, New En-
gland Medical Center): One might speculate that the increased
GFR and renal blood flow associated with water retention
increases glutamine delivery to the kidney.
DR. SCHOOLWERTFJ: Was GFR measured?
DR. MADIAS: No, but you can assume that GFR was in-
creased under these circumstances.
DR. SCHOOLWERTH: I agree. Lemieux and associates clearly
demonstrated in the early 1970s that ammonium excretion
parallels GFR and renal blood flow in acidotic dogs [118].
DR. MADIAs: I should like to counter your statement that
respiratory acidosis does not stimulate renal ammoniagenesis.
At least in the dog, Gougoux and colleagues have shown that in
the presence of stability of renal hemodynamics, renal ammonia-
genesis adapts promptly and markedly in response to hypercap-
nia. Indeed, under such circumstances, renal ammonia production
was comparable to that observed in dogs with chronic metabolic
acidosis [119]. Moreover, studies from our laboratory have shown
that during the maintenance phase of respiratory acidosis in the
dog, urinary NH4 excretion remains significantly elevated as
compared with the baseline; however, net acid excretion does not
differ from control because of accompanying bicarbonaturia and a
decrease in titratable acidity [120].
DR. SCHOOLWERTH: Did you measure ammonium production
or just excretion?
DR. MAmAS: Ammonium production was measured during
the studies of acute hypercapnia by Gougoux and colleagues
[119]. In our studies of chronic hypercapnia, only urinary
ammonium excretion was measured [120]. However, the ele-
vated ammonium excretion during the maintenance phase of
chronic hypercapnia was accompanied by an increased urine
pH as compared with baseline [120].
DR. SCHOOLWERTH: There is no question that ammonium
production and excretion increase in acute respiratory acidosis.
The increased glutamine metabolism and ammonium excretion,
together with H secretion, lead to the generation of increasing
amounts of bicarbonate ions and the well-recognized rise in
extracellular fluid bicarbonate content in chronic respiratory
acidosis. I merely suggested that the increased bicarbonate
concentration, by inhibiting succinate dehydrogenase, might
offset the stimulatory effect of acidemia on glutamine metabo-
lism such that in the steady state of chronic respiratory acido-
sis, ammonium production is not increased. This explanation is
compatible with the data obtained in rat kidney by Rodriguez-
Nichols and Tannen [721 and the finding that renal tissue aKG
is decreased in chronic metabolic acidosis and acute, but not
chronic, respiratory acidosis [121]. The substantial increase in
ammonium excretion observed in your studies might suggest
that the situation differs in the dog and rat [120]. Alternatively,
Tannen has suggested that an adaptive increase in distal, but
not proximal, proton transport occurs in chronic respiratory
acidosis [1221.
DR. RONALD PERRONE (Division of Nephrology, New En-
gland Medical Center): Could you comment on the pathophys-
iology of hyperkalemic renal tubular acidosis, in particular,
whether you believe this is a disorder of ammoniagenesis versus
a disorder of proton pumping?
DR. SCHOOLWERTH: Hyperkalemia reduces ammonium ex-
cretion [123, 124]. The decreased ammonium excretion likely
reflects the ability of the elevated potassium concentration to
decrease ammonium production [125]. Studies in chronically
hyperkalemic rats recently confirmed a significant reduction in
whole-kidney ammonium production and excretion [126]. How-
ever, chronic hyperkalemia had no effect on net ammonium
secretion or absolute ammonium delivery out of the proximal
tubule; thus reduced ammonium excretion probably is due to
some other abnormality, such as reduced ammonium transport
into collecting ducts in the medulla [1261. With regard to
hyperkalemic RTA, a decrease in both ammonium production
and ammonium entry and altered proton pumping are likely to
exist. I know of no evidence suggesting a reciprocal relationship
between ammonium and titratable acid excretion under these
circumstances. In fact, I would expect titratable acid excretion
also to be reduced in situations in which proton pumping is
impaired.
DR. MAmAs: You mentioned that in acute metabolic acidosis
in the rat, the renal cortical aKG level is decreased and the
activity of aKGDH is increased, presumably in response to the
acidification of body fluids. Yet, in the chronic phase of metabolic
acidosis, renal ammonium production is higher than acutely,
despite higher systemic and renal pH values. My question is, has
the activity of the aKGDH enzyme been looked at in chronic
metabolic acidosis as compared with the acute phase?
DR. SCHOOLWERTH: I am unaware of any data demonstrating
an increased activity of renal aKGDH in chronic metabolic
acidosis. Freeze-clamp studies of renal cortex from chronically
acidotic rats and dogs have shown that tissue aKG and gluta-
mate levels remain decreased [26]. These changes might reflect
events earlier in metabolic acidosis, but these alterations also
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might "deinhibit" both PDG and GDH, resulting in an even
greater stimulation in ammonium production than in acute
metabolic acidosis. As I mentioned previously, the regulation of
the augmented rate of ammoniagenesis in chronic metabolic
acidosis likely involves factors other than those occurring in
acute acidosis. For example, the enzymes PDG and GDH are
induced in the rat but not in the dog.
DR. MADIAs: What is the importance of the basolateral
mechanism for the entry of glutamine in the proximal tubule
cell? Some data suggest adaptation of this transporter in chronic
metabolic acidosis in the dog [1271.
DR. SCHOOLWERTH: The study you refer to revealed an
almost twofold increase in the max for glutamine uptake in
renal basolateral vesicles from dogs with metabolic acidosis
[127]. Earlier, Silverman et al had obtained evidence in vivo
that the unidirectional basolateral uptake of glutamine was not
increased in chronically acidotic as compared with normal
dogs; the data suggested no adaptation of this transporter [128].
The data further suggested that under normal acid-base condi-
tions, bidirectional transport of glutamine occurred across the
basolateral membrane, but with increased oxidation of glu-
tamine in metabolic acidosis, the cell served as a "sink" and
accounted for increased extraction. I do not believe that the
plasma membrane transport of glutamine across either the
luminal or basolateral membrane is a rate-limiting factor in the
metabolism of glutamine by renal proximal tubules.
Da. HARRINGTON: I'm interested in what happens to the
enzymes in the reverse side, that is, in chronic metabolic
alkalosis. Are these enzymes turned off as one might expect?
Specifically, what happens to alpha ketoglutarate?
DR. SCHOOLWERTH: Several laboratories have demonstrated
a decrease in rat renal PDG activity in chronic metabolic
alkalosis [14, 129]. Seyama and associates found no decrease in
GDH activity after feeding of sodium bicarbonate to rats [130].
On increasing pH, the activity of aKGDH decreases because of
a decreased affinity of the enzyme for its substrate aKG [291;
however, I am not aware of any measurements of the activity of
the enzyme in renal cortex from chronically alkalotic animals.
DR. HARRINGTON: The data you've discussed have been
obtained in rats and dogs. Are there new ways of looking at
humans to find out the answers to any of these questions? I'm
interested in both in-vitro and in-vivo studies and techniques.
DR. SCHOOLWERTH: In-vivo studies performed by Tizianello
and collaborators have demonstrated an increase in ammonium
production both in acute and chronic metabolic acidosis [24,
131]. Although glutamine extraction and ammonium production
were measured, it is difficult to identify the metabolic pathways
involved from these in-vivo studies. With increasing success in
culturing human proximal renal tubular cells, it is likely that
additional information will be forthcoming [132]. For example,
studies have evaluated the effect of pH in the medium on
glutamine metabolism in cultured human cortical cells. These
studies with radiolabeled nitrogen demonstrated an increase in
glutamate deamination following a decrease in pH [133]. Al-
though there is always a concern about dedifferentiation of cells
in culture, future studies should provide insight into the molec-
ular mechanisms regulating increased glutamine metabolism
with both acute and chronic reductions in medium pH.
DR. LEVEY: Other than urine pH, what are the factors that
regulate the proportion of ammonium that is excreted in the
urine and that is returned in the renal venous blood? What are
the effects of metabolic acidosis on these factors?
DR. SCHOOLWERTH: Other than pH, urine flow rate affects
the proportion of ammonium that is excreted, at least in urine that
is only weakly acid or mildly alkaline. In addition, a relationship
between potassium concentration and ammonium excretion has
been demonstrated; thus, potassium loading leads to a reduction
in ammonium excretion, whereas potassium depletion increases
urinary ammonium excretion [134]. Currently there is a great deal
of interest in evaluating ammonia and ammonium transport in
different nephron segments; new studies should clarify the mech-
anisms of regulation of ammonium excretion [see 135, 136]. The
complex mechanisms for the transport of ammonia and ammo-
nium also might interrelate with ammonium production. For
example, Nagami and Kurokawa have shown that an increased
luminal flow rate leads to an increase in ammonium production
from glutamine in proximal tubules [1371. The factors that affect
ammonium excretion likely pertain in metabolic acidosis. It should
be emphasized that the same factors that stimulate ammonium
production are likely to result in increased ammonium excretion.
DR. MADIAS: Does phosphate play a role in regulating the
activity of phosphate-dependent glutaminase?
DR. SCHOOLWERTH: Glutaminase is activated by phosphate,
among other anions. The maximum activation of renal PDG
occurs at high phosphate concentrations, considerably in ex-
cess of those thought to occur in vivo. To my knowledge, data
have not demonstrated an alteration in cytosolic or mitochon-
drial phosphate concentrations as a function of acid-base dis-
turbances; thus no data suggest that phosphate is an important
regulator of the enzyme in situ. However, Yu et al have
demonstrated a stimulation of ammonium production and ex-
cretion by inorganic phosphorus in rabbit kidney, and this
response might be unique to this species [138].
DR. MADIAS: Do we understand the nature of the adaptation
of ammoniagenesis in the remnant kidney?
DR. SCFIOOLWERTH: An adaptive increase in ammonium
production and excretion per remaining nephron occurs in
remnant dog and rat kidneys [6, 8]. In our studies, we evaluated
the adaptive increase in ammonium excretion and production in
the remnant kidney of rats fed 6% and 40% casein diets.
Adaptive increases in total ammonium excretion and ammo-
nium excretion per nephron were observed in the animals fed
the 40% protein, but not the 6% protein, diets. In-vitro studies
in these animals demonstrated increased ammonium production
from both glutamine and glutamate in animals with the high
protein intake. The increase was present when measured per
gram of tissue weight, per milligram of protein, or per mg of
DNA; total-kidney DNA did not change in the remnant, so
these studies were consistent with an increase in ammonium
production per cell. We also assessed enzyme activity and
found an increased activity of PDG in remnant renal cortex
from rats fed both the low- and high-protein diet. However, we
observed an increase in GDH activity only in the animals given
40%, but not 6%, protein [8]. This increase occurred without a
demonstrable change in systemic acid-base value, thus lending
support to the hypothesis that the stimulation in metabolism is
related to increased hemodynamics, specifically an increase in
sodium load and sodium reabsorption per nephron [139]. Fur-
ther work is needed to clarify the mechanisms of the adaptive
increase in ammonium production per nephron [9].
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DR. MADIAS: Has there been any further progress in the
characterization of the renal ammoniagenic factor reported by
Alleyne and colleagues in the plasma of rats with acute meta-
bolic acidosis [140]?
DR. SCHOOLWERTH: I am unaware of any studies further
characterizing the factor described by Alleyne and colleagues.
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